Table 2 Univariate analysis of anxiety/depression among 80 thymoma patients

Age (year)

0.99

0.94–1.05

0.82

Sex

0.6

0.2–1.74

0.34

Medical insurance

3.53

0.74–16.92

0.11

Myasthenia gravis

3.43

1.14–10.29

0.03

WHO pathological type

A

–

AB

2

0.11–34.82

0.63

B1

1.33

0.21–8.49

0.76

B2

0.89

0.15–5.29

0.9

B3

1.6

0.23–11.08

0.63

Masaoka stage

I

–

II

1.33

0.39–4.6

0.65

III

1.23

0.29–5.16

0.78

IV

1

0.09–10.66

1

MOMC

Confrontive

1.17

0.97–1.41

0.11

Avoidant

1.05

0.87–1.27

0.63

Rresigned

1.44

1.11–1.88

0.01

SSRS

Objective

1.15

0.73–1.8

0.55

Subjective

1.05

0.85–1.29

0.66

Utilization

0.85

0.61–1.19

0.35

Type D Persionality

3.17

1.05–9.56

0.04